Chris Weston

Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol

C. Weston, D. Adams, G. Hirschfield, 2017, BMJ Open.